Orthocell Ltd has released a press release.
CelGro Study Validates High Quality Nerve Repair
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- CelGro Accelerates Dental Implant Treatments
- Orthocell announces successful capital raising
- First Patients Complete Nerve Regeneration Trial
- Orthocell Submits AUS Regulatory Application for CelGro
- Orthocells Ortho-ATI shows 82% success rate
Later from Orthocell
- Successful CelGro Tendon Regeneration Trial
- CelGro Nerve Regeneration Results in Quadriplegic Patients
- Placement and Share Purchase Plan
- SPP Offer Document and Terms And Conditions
- US Nerve Repair Study Design Meets FDA Requirements
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell